Global Companion Diagnostics Market Report By Technology Type (Immunohistochemistry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In Situ Hybridization, Others), By Indication (Oncology, Neurology, and Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032
The global demand for Companion Diagnostics Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Companion diagnostic provides information that is essential for effective and safe use of the corresponding drug or biological product. This helps a health care professional determine whether a particular therapeutic product's benefits to patients will outweigh any potentially serious side effects or risks. The ultimate goal is to stimulate faster access to promising new treatments for patients living with serious and life-threatening diseases.
Companion diagnostics are a crucial part of personalized medicine and will likely continue to rapidly increase in the number of disease areas. The next generation of drugs has to be safer and more efficacious. Companion diagnostics are one of the tools that can generate this information and make it available to drug developers. Escalating activities of drug discovery and vaccine development will be driving the market growth. Oncology is a segment of major focus and will remain at the forefront for the foreseeable future. Companion diagnostic play a major role in oncology research and has revolutionized the treatment of cancer by allowing doctors to adjust drug therapy to achieve better clinical results. However, the high cost and uncertain reimbursement scenario in a different region are hampering the growth of the market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of companion diagnostics.
The entire companion diagnostics market has been sub-categorized into technology type, and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Technology Type
Polymerase Chain Reaction
Next Generation Sequencing
In Situ Hybridization
This section covers regional segmentation which accentuates on current and future demand for companion diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Companion Diagnostic Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the companion diagnostics market include Abbott Laboratories Molecular, Inc., Agilent, ARUP Laboratories, Inc., BioMerieux SA, Danaher Corporation. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Companion Diagnostics Market
2.2. Global Companion Diagnostics Market Snapshot
3 . COMPANION DIAGNOSTICS – INDUSTRY ANALYSIS
3.2. Market Drivers of Companion Diagnostics Market
3.3. Market Restraints of Companion Diagnostics Market
3.4. Opportunities of Companion Diagnostics Market
3.5. Trends of Companion Diagnostics Market
3.6. Porter's Five Force Analysis of Companion Diagnostics Market
3.7. Companion Diagnostics Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Technology Type
3.7.2 Market Attractive Analysis by Indication
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Companion Diagnostics Value Chain Analysis
4.2. Companion Diagnostics Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Companion Diagnostics Raw Material Manufactures List
4.2.3. Price Trend of Companion Diagnostics Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak on Companion Diagnostics Market
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Finan ...